
### [MONDO:0017049](http://purl.obolibrary.org/obo/MONDO_0017049)
**Label:** hypomyelination neuropathy-arthrogryposis syndrome

**Subclasses:** [MONDO:0014570](http://purl.obolibrary.org/obo/MONDO_0014570) (lethal congenital contracture syndrome 8), [MONDO:0014569](http://purl.obolibrary.org/obo/MONDO_0014569) (lethal congenital contracture syndrome 7), 

**Mapped go classes:** [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:0006171](http://purl.obolibrary.org/obo/GO_0006171) (cAMP biosynthetic process), [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0033270](http://purl.obolibrary.org/obo/GO_0033270) (paranode region of axon), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0004016](http://purl.obolibrary.org/obo/GO_0004016) (adenylate cyclase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0022011](http://purl.obolibrary.org/obo/GO_0022011) (myelination in peripheral nervous system), [GO:0030913](http://purl.obolibrary.org/obo/GO_0030913) (paranodal junction assembly), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), 

**Class expressions from DL-Learner:**

- [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) 62.50%
- [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) and [GO:1901137](http://purl.obolibrary.org/obo/GO_1901137) (carbohydrate derivative biosynthetic process) 62.50%
- [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) and [GO:1901135](http://purl.obolibrary.org/obo/GO_1901135) (carbohydrate derivative metabolic process) 62.50%
- [GO:0046390](http://purl.obolibrary.org/obo/GO_0046390) (ribose phosphate biosynthetic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 62.50%
- [GO:0019693](http://purl.obolibrary.org/obo/GO_0019693) (ribose phosphate metabolic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 62.50%
- [GO:0009260](http://purl.obolibrary.org/obo/GO_0009260) (ribonucleotide biosynthetic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 62.50%
- [GO:0009259](http://purl.obolibrary.org/obo/GO_0009259) (ribonucleotide metabolic process) and [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) and [GO:1901566](http://purl.obolibrary.org/obo/GO_1901566) (organonitrogen compound biosynthetic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) and [GO:1901564](http://purl.obolibrary.org/obo/GO_1901564) (organonitrogen compound metabolic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) and [GO:1901137](http://purl.obolibrary.org/obo/GO_1901137) (carbohydrate derivative biosynthetic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) and [GO:1901135](http://purl.obolibrary.org/obo/GO_1901135) (carbohydrate derivative metabolic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) and [GO:0072522](http://purl.obolibrary.org/obo/GO_0072522) (purine-containing compound biosynthetic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) and [GO:0072521](http://purl.obolibrary.org/obo/GO_0072521) (purine-containing compound metabolic process) 62.50%
- [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process) and [GO:0046390](http://purl.obolibrary.org/obo/GO_0046390) (ribose phosphate biosynthetic process) 62.50%


